American Capital Management’s Gilead Sciences GILD Stock Holding History

American Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-34,431	Closed	-$2.47M	–	78
2017 Q4	$2.47M	Sell	34,431 -5,115	-13%	-$388K	0.15%	58
2017 Q3	$3.2M	Sell	39,546 -1,754	-4%	-$134K	0.2%	55
2017 Q2	$2.92M	Sell	41,300 -2,636	-6%	-$175K	0.19%	58
2017 Q1	$2.98M	Sell	43,936 -6,284	-13%	-$442K	0.21%	58
2016 Q4	$3.6M	Sell	50,220 -1,641	-3%	-$122K	0.28%	61
2016 Q3	$4.1M	Buy	+51,861	New	+$4.21M	0.32%	57
2016 Q2	–	Sell	-52,952	Closed	-$4.86M	–	134
2016 Q1	$4.86M	Buy	52,952 +42	+0.1%	+$3.79K	0.42%	56
2015 Q4	$5.35M	Buy	+52,910	New	+$5.51M	0.48%	51

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

American Capital Management's GILD Position: Q1 2018 in Review

American Capital Management sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 34,431 shares — an estimated $2.47M sold.

American Capital Management first reported a position in GILD in Q4 2015 and held it in 8 quarters. The position peaked at $5.35M in Q4 2015. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

American Capital Management reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
American Capital Management sold 34,431 Gilead Sciences shares in Q1 2018, an estimated $2.47M.
American Capital Management first reported a position in Gilead Sciences in Q4 2015 and held it in 8 quarters.
American Capital Management's Gilead Sciences position peaked at $5.35M in Q4 2015.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on American Capital Management's 13F filing for Q1 2018, filed 23 Apr 2018.